Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlliance Pharma Regulatory News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 34.95
Bid: 34.65
Ask: 34.70
Change: 3.35 (10.60%)
Spread: 0.05 (0.144%)
Open: 31.00
High: 35.10
Low: 31.00
Prev. Close: 31.60
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proactive Investors Presentation

15 May 2013 07:00

RNS Number : 7241E
Alliance Pharma PLC
15 May 2013
 



For immediate release

15 May 2013

 

RNS REACH

 

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

 

Alliance Pharma to present at Proactive Investors Forum

 

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, is pleased to announce that John Dawson, CEO of Alliance Pharma, will be presenting on the Company at an upcoming Proactive Investors Forum on Thursday 16 May 2013 in London.

 

The event starts at 6.00pm and is open to private investors, private client brokers, fund managers, financial institutions, hedge funds, buy and sell side analysts and journalists.

 

The event will be held at the Chesterfield Mayfair Hotel, 35 Charles Street, Mayfair, London W1J 5EB in the Charles Suite.

 

For further information, and to register, please go to:

http://www.proactiveinvestors.co.uk/register/event_details/189

 

 

 

For further information:

 

Alliance Pharma plc

+ 44 (0) 1249 466966

John Dawson, Chief Executive

Richard Wright, Finance Director

www.alliancepharma.co.uk

Buchanan

+ 44 (0) 20 7466 5000

Mark Court / Fiona Henson / Sophie Cowles

www.buchanan.uk.com

Numis Securities Limited

+ 44 (0) 20 7260 1000

Nominated Adviser: Michael Meade / Oliver Cardigan

Corporate Broking: David Poutney

 

Notes to editors:

 

About Alliance

 

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

 

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAUSOWROBAVAAR
Date   Source Headline
8th Mar 20124:00 pmRNSCULS Conversion
2nd Feb 20127:00 amRNSNotification of Preliminary Results
16th Jan 20127:00 amRNSPre-Close Trading Update
19th Dec 20117:00 amRNSAcquisition of Brands
21st Oct 20115:56 pmRNSExercise of Options
21st Sep 20113:30 pmRNSExercise of Options
16th Sep 20112:22 pmRNSExercise of Options
7th Sep 201110:53 amRNSInterim Dividend
7th Sep 20117:01 amRNSAcquisition
7th Sep 20117:00 amRNSInterim Results
10th Aug 20111:20 pmRNSNotification of major interest in shares
9th Aug 20117:00 amRNSNotification of Major Interest in Shares
3rd Aug 20117:00 amRNSNotice of Interim Results
6th Jul 20117:00 amRNSPre-Close Trading Update
16th Jun 20115:59 pmRNSNotification of Major Interest in Shares
10th Jun 20119:41 amRNSExercise of Share Options
7th Jun 20115:21 pmRNSCULS Conversion
26th May 20115:32 pmRNSExercise of Share Options
26th May 20117:00 amRNSAGM Statement
24th May 20114:02 pmRNSExercise of Share Options
20th May 20117:00 amRNSExercise of Share Options
17th May 20117:00 amRNSRenewal of Agreement
13th May 20114:25 pmRNSMajor Interest in Shares
6th May 20114:58 pmRNSExercise of Share Options
28th Apr 20115:40 pmRNSExercise of Options
28th Apr 20114:46 pmRNSShare Options
28th Apr 20117:00 amRNSCULS Conversion
20th Apr 20114:02 pmRNSAnnual Report and AGM Notice
19th Apr 20113:40 pmRNSDirector Shareholding
19th Apr 20112:27 pmRNSCompletion of Acquisition
13th Apr 20114:13 pmRNSNotification of Interest in Shares
23rd Mar 20117:01 amRNSProposed Acquisition
23rd Mar 20117:00 amRNSPreliminary Results
15th Mar 20117:00 amRNSCULS Conversion
2nd Feb 201112:38 pmRNSMajor Interest in Shares
25th Jan 201111:26 amRNSExercise of Options
25th Jan 20118:50 amRNSCULS Conversion
21st Jan 20115:49 pmRNSMajor Interest in Shares
12th Jan 20117:00 amRNSPre-close Trading Update
11th Jan 20111:43 pmRNSCULS Conversion
20th Dec 201010:11 amRNSCULS Conversion
3rd Dec 20104:45 pmRNSNotice of Major Interest in Shares
25th Nov 20102:06 pmRNSCULS Conversion
25th Nov 20107:00 amRNS£44 million Bank Facilities
15th Nov 20104:24 pmRNSMajor Interests in Shares
9th Nov 20108:44 amRNSCULS Conversion and Additional Listing
5th Nov 20102:19 pmRNSExercise of Options
11th Oct 20102:45 pmRNSDirector Shareholding
29th Sep 201012:26 pmRNSExercise of Options
20th Sep 201012:31 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.